Point72 Asset Management

Undisclosed raised $28M on February 3, 2023

Investors: Point72 Asset Management

Delfi Diagnostics raised $225M on July 18, 2022

Investors: PTX Capital, OrbiMed Advisors, -, T. Rowe Price, Osage University Partners (OUP), Samsara BioCapital, Windham Venture Partners, Point Field Partners and Point72 Asset Management

Kinly raised $15M on June 13, 2022

Investors: Forerunner, Kapor Capital, Anthemis Group and Point72 Asset Management

Atomic Industries raised $3.2M on April 5, 2022

Investors: Y Combinator, 8VC, Toyota Ventures and Point72 Asset Management

Korro Bio, Inc. raised $116M on January 5, 2022

Investors: MP Healthcare Venture Management Inc, Qiming Venture Partners USA, The Invus Group, Surveyor Capital, Sixty Degree Capital, Monashee Investment Management LLC, Wu Capital （双湖资本） and Point72 Asset Management

Quell Therapeutics raised $156M on November 29, 2021

Investors: SV Life Sciences, Tekla Capital Management, Syncona Limited, Monashee Investment Management LLC, JEITO, British Patient Capital, Ridgeback Capital Management LLC and Point72 Asset Management

LÜK raised $4M on November 1, 2021

Investors: Nyca Partners, LAUNCH and Point72 Asset Management

Vestwell raised $70M on July 20, 2021

Investors: Manulife Financial, Teamworthy Ventures, Greenspring Associates, Industry Ventures and Point72 Asset Management

Turnstone Biologics raised $80M on July 14, 2021

Investors: Partner Fund Management, Sectoral Asset Management, Takeda UK Limited, OrbiMed Advisors, Ridgeback Capital Management LLC, Teralys Capital, Surveyor Capital, Versant Ventures, Sixty Degree Capital and Point72 Asset Management

BioTheryX, Inc. raised $92M on May 20, 2021

Investors: Irving Investors, Lumira Ventures, Surveyor Capital, Wedbush Securities, Farallon Capital Management, S.R. One Ltd, Tekla Capital Management and Point72 Asset Management